Skip to main content

Table 2 Infection characteristics and evolution during the ICU stay *.

From: Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective study

characteristics

PIP-TAZ R n = 13

PIP-TAZ S n = 70

p

Time of onset of the infection

   

   From hospital admission

22 ± 32

10 ± 21

0.03

   From ICU admission

7 ± 12

5 ± 10

NS

Nosocomially/community acquired

10 (77)

36 (51)

NS

Locations of infection

   

   Pneumonia

3 (27)

29 (41)

NS

   Urinary tract

4 (31)

24 (34)

NS

   Intra-abdominal

1 (9)

10 (14)

NS

   Isolated bacteremia

4 (31)

1 (1)

0.007

   Other sites

1 (9)

6 (9)

NS

Infection-related complications

   

   Septic shock

6 (46)

23 (33)

NS

   ARDS

6 (46)

14 (20)

NS

   MOF

4 (31)

14 (20)

NS

   Superinfections

0

1 (1)

NS

   Relapses

0

2 (3)

NS

Outcome

   

   Length of stay in ICU

26 ± 33

21 ± 22

NS

   Death during ICU stay

6

27

NS

  1. * Data are presented as No (%) or mean ± SD